ATE397662T1 - Neues polypeptid, dafür kodierende dna und deren verwendungen - Google Patents

Neues polypeptid, dafür kodierende dna und deren verwendungen

Info

Publication number
ATE397662T1
ATE397662T1 AT98905674T AT98905674T ATE397662T1 AT E397662 T1 ATE397662 T1 AT E397662T1 AT 98905674 T AT98905674 T AT 98905674T AT 98905674 T AT98905674 T AT 98905674T AT E397662 T1 ATE397662 T1 AT E397662T1
Authority
AT
Austria
Prior art keywords
polypeptide
dna coding
new polypeptide
antibody
dna
Prior art date
Application number
AT98905674T
Other languages
English (en)
Inventor
Hideaki Tada
Mikio Konishi
Daikichi Fukushima
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of ATE397662T1 publication Critical patent/ATE397662T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT98905674T 1997-02-27 1998-02-26 Neues polypeptid, dafür kodierende dna und deren verwendungen ATE397662T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4314397 1997-02-27

Publications (1)

Publication Number Publication Date
ATE397662T1 true ATE397662T1 (de) 2008-06-15

Family

ID=12655623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98905674T ATE397662T1 (de) 1997-02-27 1998-02-26 Neues polypeptid, dafür kodierende dna und deren verwendungen

Country Status (9)

Country Link
US (3) US7396908B2 (de)
EP (1) EP0990703B1 (de)
KR (1) KR20000075749A (de)
AT (1) ATE397662T1 (de)
DE (1) DE69839582D1 (de)
DK (1) DK0990703T3 (de)
ES (1) ES2307313T3 (de)
PT (1) PT990703E (de)
WO (1) WO1998038304A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011791A2 (en) * 1997-09-05 1999-03-11 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
CA2301173C (en) 1997-09-12 2015-04-14 Biogen, Inc. Cysteine rich receptors-train
IL136988A0 (en) * 1997-12-29 2001-06-14 Regeneron Pharma Novel nucleic acid and polypeptide
WO1999037818A1 (en) * 1998-01-27 1999-07-29 Millennium Pharmaceuticals, Inc. Novel molecules of the tnf receptor superfamily and uses therefor
AU2574200A (en) * 1999-02-19 2000-09-04 Toshio Kitamura Novel tnf receptor-like proteins
CA2381327A1 (en) * 1999-07-16 2001-01-25 Steven M. Ruben Human tumor necrosis factor receptors tr13 and tr14
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
MXPA02007787A (es) * 2000-02-11 2004-09-10 Inst Genetics Llc Moleculas trade y uso relacionado con las mismas.
US7067148B2 (en) 2001-02-15 2006-06-27 King Pharmaceutical Research & Development, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
EP1789070B1 (de) 2004-08-03 2012-10-24 Biogen Idec MA Inc. Taj in der neuronalen funktion
EP3409686B1 (de) 2012-07-18 2022-04-13 Apogenix AG Zusammensetzung mit einer mischung aus cd95-fc-isoformen
CN104755458B (zh) † 2012-10-24 2017-06-20 巴斯夫欧洲公司 通过在液相中光气化胺制备异氰酸酯的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214857D0 (en) 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
CA2301173C (en) 1997-09-12 2015-04-14 Biogen, Inc. Cysteine rich receptors-train

Also Published As

Publication number Publication date
US20100298546A1 (en) 2010-11-25
EP0990703A4 (de) 2001-09-12
US7705140B2 (en) 2010-04-27
US7396908B2 (en) 2008-07-08
US8008451B2 (en) 2011-08-30
ES2307313T3 (es) 2008-11-16
WO1998038304A1 (en) 1998-09-03
PT990703E (pt) 2008-08-27
EP0990703B1 (de) 2008-06-04
US20080175843A1 (en) 2008-07-24
US20040142423A1 (en) 2004-07-22
DE69839582D1 (de) 2008-07-17
KR20000075749A (ko) 2000-12-26
EP0990703A1 (de) 2000-04-05
DK0990703T3 (da) 2008-09-29

Similar Documents

Publication Publication Date Title
ATE444361T1 (de) Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen
ATE397662T1 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
HU9600692D0 (en) Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
SI0994728T1 (sl) Rekombinantna protitelesa, specifična za beta-amiloidne konce, kodirana z DNA ter postopki za njihovo uporabo
ES2193145T3 (es) Proteinas procoagulants quimericas.
LU91759I9 (de)
IL143670A0 (en) Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same
DE69839444D1 (de) Smad 6 und dessen anwendungen
DE69433690D1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
IL85878A0 (en) Anticoagulant proteins,dna coding for them,processes for preparing them,pharmaceutical compositions containing them,monoclonal antibodies against such proteins and hybrid cell lines which secrete these antibodies
ATE242323T1 (de) Transportprotein, das den transport von kationischen xenobiotika und/oder pharmaka bewirkt, dafür kodierende dna-sequenzen und deren verwendung
EE200000151A (et) Aminoterminaalselt kärbitud rantes vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
DK0817851T3 (da) DNA, der koder for humant papillomvirus type 18
BR0312889A (pt) Polipeptìdeo t20 peguilado
ATE385517T1 (de) Interferon ähnliche moleküle, und deren verwendungen
EP0692532A4 (de) Neuartige polypeptide, ihre dna, rekombinanter vektor der letzter enthält, mit diesem hergestellter rekombinanter virus und seine verwendung
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ATE190630T1 (de) Angiotensin-ii typ-1 rezeptor und dessen herstellung
NO980122D0 (no) Emaljematriksrelatert polypeptid
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
DE69941099D1 (de) Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria
ATE111920T1 (de) Lymphokine, dns-sequenzen, die diese lymphokine kodieren, und sie enthaltende pharmazeutische zusammensetzungen.
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium
EP1019500A4 (de) Neue ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0990703

Country of ref document: EP

REN Ceased due to non-payment of the annual fee